Delivery Order SPE2DB22D1017-SPE2DB25FG5HA
- Not listed
- The Defense Logistics Agency awarded a delivery order valued at $6,690.93 to AmerisourceBergen Drug Corp for Actemra Actpen 162 mg/0.9 ml auto-injector pens. The contract was awarded on September 8, 2025, with an ultimate completion date of September 9, 2025, and employs firm fixed price terms with no set-aside designation. Performance will take place at AmerisourceBergen's corporate headquarters in Conshohocken, Pennsylvania. This delivery order is issued under the company's larger Indefinite...
- The Defense Logistics Agency awarded a delivery order valued at $1,143.94 to AmerisourceBergen Drug Corp for the supply of Actemra ActPen 162 mg/0.9 mL auto-injector pens. This firm fixed price delivery order was competitively awarded without set-aside designation and is scheduled for completion by September 9, 2025. The product will be delivered to AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, where the company maintains its primary operations as a major...
- The Defense Logistics Agency awarded a delivery order valued at $2,287.88 to AmerisourceBergen Drug Corp for Actemra Actpen 162 mg/0.9 mL auto-injector pens on August 19, 2025, with an ultimate completion date of August 20, 2025. This competitively awarded, non-set-aside contract utilizes firm fixed pricing and represents a child delivery order under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (contract SPE2DX), valued at $999,999,999.00 and extending...
- The Defense Logistics Agency awarded a delivery order valued at $15,757.28 to AmerisourceBergen Drug Corp for the supply of Actemra Actpen 162 mg/0.9 mL auto-injector pens. The contract, awarded on September 8, 2025, with an ultimate completion date of September 9, 2025, is structured as a firm fixed-price delivery order with no set-aside designation, indicating competitive award. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, will...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $1,715.91 to AmerisourceBergen Drug Corp for the supply of Actemra Actpen 162 mg/0.9 ml auto-injectors. This firm fixed-price delivery order, issued on September 3, 2025, with an ultimate completion date of September 4, 2025, represents a non-set-aside competitive award. The pharmaceutical product will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued...
- The Defense Logistics Agency Medical Supply Chain awarded a delivery order valued at $19,218.06 to AmerisourceBergen Drug Corp on September 17, 2025, for the supply of Actemra ActPen 162 mg/0.9 mL auto-injectors. This is a firm fixed-price, non-competitive set-aside delivery order with an ultimate completion date of September 18, 2025, and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The award represents a child contract under a larger...
- AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, received a delivery order award from the Defense Logistics Agency (DLA) on September 9, 2025, for the supply of Actemra ActPen 162 mg/0.9 mL auto-injectors. The contract is valued at $3,431.82 with a firm fixed price structure and an ultimate completion date of September 10, 2025. This delivery order was awarded competitively with no set-aside designation and represents a child contract...
- The Defense Logistics Agency awarded a delivery order valued at $5,092.00 to AmerisourceBergen Drug Corp for the supply of Actemra ActPen 162 mg/0.9 ml auto-injectors. The award was made on August 25, 2025, with an ultimate completion date of August 26, 2025, under a firm fixed-price contract type with no set-aside designation. Performance will take place at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under the company's larger...
- The Defense Logistics Agency awarded a $2,877.84 delivery order to AmerisourceBergen Drug Corp for Actemra ActPen 162 mg/0.9 mL auto-injector pens on July 24, 2025, with an ultimate completion date of July 25, 2025. This firm fixed-price delivery order was competitively awarded without set-aside designation and will be fulfilled at the vendor's corporate office location in Conshohocken, Pennsylvania. The contract represents a child delivery order issued under AmerisourceBergen's larger...
- The Defense Logistics Agency awarded a delivery order valued at $6,922.53 to AmerisourceBergen Drug Corp for the supply of Actemra ActPen 162 mg/0.9 mL auto-injectors. This competitively awarded, firm fixed-price contract was executed on June 17, 2025, with an ultimate completion date of June 18, 2025. The pharmaceutical products will be delivered to the Conshohocken, Pennsylvania location, where AmerisourceBergen maintains its corporate headquarters. As a major pharmaceutical distributor and...
- SPE2DB22D1017Indefinite Delivery Contract
- SPE2DB22D1017-SPE2DB25FG5HADelivery Order
The Defense Logistics Agency (DLA) awarded a delivery order valued at $2,877.84 to AmerisourceBergen Drug Corp for the supply of Actemra Actpen 162 mg/0.9 mL auto-injector pens. This firm fixed-price contract was competitively awarded without set-asides and is scheduled for completion by June 20, 2025. The contract will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX, which carries a potential value of $999,999,999.00 through December 2026 and serves as a comprehensive global pharmaceutical support vehicle for military healthcare programs. AmerisourceBergen's IDC with DLA enables the company to supply a broad range of pharmaceutical products and medical supplies to support Defense Health Agency operations and other federal healthcare systems worldwide. The Actemra product being procured under this delivery order is a specialty biologic medication used for treating rheumatoid arthritis and other inflammatory conditions, reflecting the company's critical role in supplying specialized therapeutics to military and veteran healthcare systems. As a major pharmaceutical distributor and established federal healthcare vendor, AmerisourceBergen maintains a significant portfolio of competitively awarded contracts with DLA across multiple therapeutic domains, demonstrating its capability to meet federal procurement requirements for both routine and specialty medical products.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $2.9k | 6/18/25 |